Navigation Links
Abaxis Reports Financial Performance For The Fourth Quarter And Fiscal 2013
Date:4/25/2013

pany is our higher margin consumable sales, which increased 16 percent in the fourth quarter and represented 72 percent of total fourth quarter revenue.  We remain firmly focused on maximizing this core component of our business which constitutes our recurring revenue stream."

"Fiscal year 2013 marks the 12th consecutive year of profitability for Abaxis.  Given the challenging global macroeconomic conditions of the past five years, we are extremely proud of our ability to operate effectively and profitably in uncertain times," continued Mr. Severson.  "The financial underpinnings of the company are very strong.  We maintain a solid cash position, which provides us a level of stability during these difficult times.  During fiscal year 2013, we paid a special one-time dividend to our loyal shareholders.  Looking ahead, we are excited about our strategic initiatives and the opportunities with our new distributors, Abbott Point of Care, Inc. for medical products and MWI Veterinary Supply, Inc. for animal health products.  Our expectation is that as the medical market distribution channel becomes more developed in the coming quarters, medical market products will also become consistent double-digit growers.  We are excited with the possibilities ahead."

Conference CallAbaxis has scheduled a conference call to discuss its results at 4:15 p.m. Eastern Time on Thursday, April 25, 2013.  Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the company's website at http://www.abaxis.com.  A replay of the call will be available by visiting http://www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10027780, through May 1, 2013.  This press release is also ava
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Abaxis To Report Fourth Quarter And Fiscal Year 2013 Financial Results Thursday, April 25, 2013
2. Abaxis, Inc. to Present at the Sidoti & Company Seventeenth Annual Institutional Investor Forum
3. Abaxis, Inc. to Present at the Raymond James 34th Annual Institutional Investor Conference
4. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
5. Abaxis Reports Record Revenues For The Third Quarter Of Fiscal 2013
6. Abaxis To Report Third Quarter Fiscal Year 2013 Financial Results Thursday, January 31, 2013
7. Abaxis Declares Special Cash Dividend of $1.00 Per Share
8. Abaxis, Inc. to Present at 24th Annual Piper Jaffray Healthcare Conference
9. Abaxis, Inc. to Participate in Sidoti & Companys Inaugural One-on-One Conference
10. Abaxis, Inc. to Present at the Stephens Fall Investment Conference
11. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , February 27, 2015 ... 2014 market research report to its store. This ... Ulcers, therapeutic pipeline. The report "Corneal ... the therapeutic development for Corneal Ulcers. Corneal Ulcers ... includes bacterial infections, viral infections & fungal infections. ...
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
(Date:2/26/2015)... 26, 2015 Every year many millions of ... heart disease.  Nevertheless, year after year doctors and the ... the first test to determine the status of heart ... or not, even though that technology is over 100 ... that doctors know, (while most patients do not know) ...
Breaking Medicine Technology:Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2National Heart Health Month In February 2
... Expands Enterprise Intelligence Systems to Healthcare Market, ... Booth #1841 --,Harris Corporation (NYSE: HRS ... has joined forces with Cancer Treatment,Services International ... of,radiation oncology. Harris will provide advanced imaging ...
... InteKrin Therapeutics, Inc.,a privately-held clinical stage biopharmaceutical ... novel drugs for the treatment of,diabetes, obesity ... has,initiated a Phase 2b study in diabetic ... non-TZD SPPARM (Selective Peroxisome,Proliferator-Activated Receptor Modulator). INT131 ...
Cached Medicine Technology:Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131 2
(Date:2/26/2015)... As the great passage beyond midlife gathers ... more substantial roles and connections that span the generations ... a life that still matters? As The Aspen Club ... Year Total Immersion Retreat , answers to these types ... and jump-starts a healthier life. A new round of ...
(Date:2/26/2015)... Imagine a day without access to clean, drinkable water ... was no one to help. For more than 783 million ... more than 2.5 billion people will also lack access to ... initiative led by Nevada’s Desert Research Institute (DRI) ... women – who often bear the brunt of the impact ...
(Date:2/26/2015)... NY (PRWEB) February 26, 2015 The ... with Topical BioMedics, Inc., Rhinebeck, NY, to offer customers ... creams—patented topical biomedicine formulas that safely and effectively address ... a new division of Vets Access LLC, Montrose, MI, ... and healing products. , Topical BioMedics is a research ...
(Date:2/26/2015)... Scotch Plains, NJ (PRWEB) February 26, 2015 ... celebrating the reopening of their newly renovated office in ... Mann, the Reproductive Science Center of New Jersey’s physicians, ... outstanding work and patient care in the areas of ... is commended for having excellent success rates and providing ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Beckman Coulter ... of extracellular vesicles and their cargo in cell-to-cell communication,” ... and their relevance for cell-to-cell communication. The webinar is ... 4, 2015 at 8:00am PT. , Every cell in ... vesicles (EVs) , often called “exosomes” or “microvesicles.” These ...
Breaking Medicine News(10 mins):Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 2Health News:COR HEALTH Division of Vets Access Partners with Topical BioMedics to Provide Natural Pain Relief Products 3Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 2Health News:RSCNJ Is Celebrating the Reopening of Their Newly Renovated Office 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3
... release are posted on the Mayo,Clinic News Blog: http://newsblog.mayoclinic.org/ ... for TV broadcast upon request., ROCHESTER, Minn. July 31 ... both men and women. For men,the record pace for the ... the 10,000-meter run just after World War II. Today, champion ...
... "open access" or free online, they get read more ... -- get cited more often in academic literature, finds ... student Philip Davis and colleagues, including three Cornell professors, ... access they need to relevant articles. , "It appears ...
... (Nasdaq:,EVVV) today announced that Pat Spangler, chief financial officer, ... at the,Canaccord Adams 28th Annual Global Growth Conference on ... Canaccord Adams 28th Annual Global,Growth Conference will be held ... the webcast, go to the investors, section of the ...
... 31 Halozyme Therapeutics,Inc. (Nasdaq: HALO ), ... extracellular matrix, today,announced that it will release financial ... 30, 2008 before market open on Friday, August ... Chief Executive Officer, Gregory Frost,PhD, Vice President and ...
... of Michigan to spray the state,s apple orchards with ... to treat blood infections in newborns and other serious ... America (IDSA). , The Environmental Protection Agency (EPA) ... to use gentamicin to fight a tree disease called ...
... Stereotaxis, Inc. (Nasdaq:,STXS) announced today that it ... ended June 30, 2008, on Tuesday, August 5, ... a conference call and webcast on,Tuesday, August 5, ... the Company,s,second quarter results and current corporate developments. ...
Cached Medicine News:Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 2Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 3Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 4Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 5Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 6Health News:Mayo Clinic on the Summer Olympic Games: Better Athletes, the Physiology of Performance, the Lactate Threshold, the Aging Athlete and Much More 7Health News:Free articles get read but don't generate more citations 2Health News:Halozyme Therapeutics to Hold Pipeline Update Conference Call on August 8 2Health News:Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?' 2
... is the most potent, naturally secreted estrogen ... the ovary [1]. In the ovary, estradiol ... estrone, a less potent estrogen derived from ... many body tissues. In men, small amounts ...
The second-generation Dade Behring Acute Care Troponin I (cTnI) method is the first FDA cleared high sensitivity cTnI assay with the low-end precision necessary to meet the ESC/ACC guidelines (CV <10...
For the quantitative measurement of CKMB, Myoglobin, and Troponin-I in human serum....
... to the National Academy of ... use of cardiac markers in ... is definitive of acute myocardial ... assay was designed for rapid ...
Medicine Products: